Arbovirus Diagnostic Tests Market: Introduction
- Arboviral disease is an infection caused by a group of viruses spread to humans by the bite of insects (infected arthropods). Examples include Chikungunya, St. Louis encephalitis, yellow fever, California encephalitis, Eastern equine encephalitis, dengue, West Nile, and Zika.
- There are more than 500 known arboviruses, of which around 100 are capable of causing diseases in humans. The major arthropod vectors of arboviruses are mosquitoes, ticks, sandflies, and biting midges.
- The types of virus range in severity of diseases from no symptoms to mild flu-like to severe symptoms. Most people infected with arboviruses experience no symptoms or mild symptoms such as headache, slight fever, and/or a skin rash, muscle or joint pain, which resolve with no serious health complications. Severe infections are marked by a rapid onset of fever, headache, tremors, confusion, seizures, coma, paralysis, or death.
- Asymptomatic arboviral infections are of two types: neuroinvasive arboviral infection and non-neuroinvasive arboviral infection
- Neuroinvasive arboviral infection includes encephalitis, aseptic meningitis, or acute flaccid paralysis. These illnesses are characterized by stiff neck, weakness, acute onset of fever with a headache, myalgia, seizures, or disturbed mental state.
- In non-neuroinvasive disease, the virus is capable of causing an acute systemic febrile illness. It cannot be transferred from human to human, rather it is transferred from human-to-mosquito-to-human.
- Arboviral diagnostics help to detect the transmitted virus by infected arthropods (insects) to humans and to distinguish between an infection and other similar conditions
- Arbovirus diagnostics either detect the antibodies produced by the body’s immune system in response to particular arbovirus or virus’s genetic material
Key Drivers and Restraints of Global Arbovirus Diagnostic Tests Market
- Increase in incidence and prevalence of arbovirus is projected to boost the growth of the global arbovirus diagnostic tests market in the next few years
- According to the National Center for Biotechnology Information (NCBI), arthropod-borne pathogens account more than 17% of infectious diseases, affect millions of people across the world each year, and comprise a significant proportion of emerging human pathogens. Dengue is the most widespread arboviral disease, which is responsible for over 90 million cases and nearly 40,000 deaths per year. High prevalence of arboviral disease in developing and developed countries is anticipated to boost the growth of the global arbovirus diagnostic tests market.
- Increase in morbidity and mortality rates of arbovirus diseases has led to increase in initiatives by governments to manage the number of cases, rise in awareness, and evolving health care facilities. These factors propel the global arbovirus diagnostic tests market.
- Top manufacturers and researchers focus on finding new and cost-effective ways to diagnose the arbovirus to produce results in time. Moreover, advancements in technology in the field of arbovirus diagnostics to fulfill the need of point-of-care diagnostic tests in the market are expected to augment the global market during the forecast period.
- However, lack of in vitro facilities, inaccurate results from traditional diagnostic tests, and lack of awareness are the factors likely to restrain the global market during the forecast period
North America to Lead Global Arbovirus Diagnostic Tests Market
- In terms of region, the global arbovirus diagnostic tests market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is projected to dominate the global market during the forecast period, followed by Europe. Increase in geriatric population, rise in incidence and prevalence of arbovirus, well-established health care infrastructure, surge in research & development expenditure, higher adoption of advanced diagnostic tests, and higher health care spending propel the arbovirus diagnostic tests market in North America and Europe.
- The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. The market is driven by India and China owing to large patient base, increase in incidence of arbovirus, rapid local transmission of arbovirus across Asia Pacific due to seasonal outbreaks, surge in awareness, increase in government initiatives toward improving health, and developing health care infrastructure.
- The market in Latin America and Africa is expected to grow at a rapid pace in the next few years, owing to high prevalence of arbovirus disease
- The Middle East is likely to account for smallest share of the global market due to less prevalence of arboviral diseases and less funding available
Key Manufacturers Operating in Global Arbovirus Diagnostic Tests Market
Key manufacturers operating in the global market are:
- Abbott
- Becton, Dickinson and Company (BD)
- Merck KGaA
- Bio-Rad Laboratories
- bioMerieux SA
- Hologic, Inc.
- QIAGEN N.V.
- Roche Molecular Systems, Inc.
- Danaher Corporation
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
Global Arbovirus Diagnostic Tests Market: Research Scope
Global Arbovirus Diagnostic Tests Market, by Test Type
- Molecular Tests
- Viral Culture Tests
- Immunoassays
- Others
Global Arbovirus Diagnostic Tests Market, by End-user
- Hospitals
- Diagnostic Laboratories
- Research Centers
- Others
Global Arbovirus Diagnostic Tests Market, by Region
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
